Purpose
This study aimed to evaluate the efficacy of indocyanine green (ICG)-fluorescence imaging for the identification of hepatic boundaries during liver resection and its advantages in surgical outcomes over conventional methods.
Methods
This prospective, exploratory, single-arm clinical trial included 47 patients with liver tumors who underwent liver resection using ICG-fluorescence imaging (ICG-LR) between 2019 and 2020. The primary outcome measure was the successful identification of hepatic boundaries during liver resection, from the perspective of both the hepatic surface and intrahepatic boundary, using ICG-fluorescence imaging. Secondary outcomes comprised the surgical outcomes. Surgical outcomes of the ICG-LR group, which included patients with successfully identified hepatic boundaries, were then compared with those who underwent conventional liver resection (C-LR, n = 100) between 2017 and 2018, using propensity score matching (PSM) analysis.
Results
Hepatic boundaries were successfully identified in 28 patients (60%; 95% confidence interval [CI], 45–72%), including 21 who underwent anatomical liver resection and seven who underwent non-anatomical liver resection. After PSM, 27 patients were included in each of the ICG-LR and C-LR groups. The surgical outcomes were similar between groups. Subsequently, surgical outcomes were compared between the groups focusing on anatomical liver resection. After PSM, 16 patients were included in each group. The C-LR group had a higher rate of Clavien–Dindo grade ≥ IIIa complication, including ascites and bile leak, than the ICG-LR group (25% vs. 0%; P = 0.033).
Conclusion
ICG-fluorescence imaging can be used to recognize hepatic boundaries during liver transection. Additionally, ICG-LR may be useful in preventing severe liver-associated complications.